Abstract
Poor and late diagnosis of HCV is main the cause of liver cancer. MicroRNAs are non-coding molecules that are involved in regulation of a variety of functions happening in the cell, in healthy and diseased state. Dysregulation of microRNAs is observed in different diseases, especially in liver cancer like hepatocellular carcinoma. The available detection methods detect HCC at a late stage. There is a need to find novel biomarkers for diagnosis at an earlier stage to minimize chances of liver cancer. Circulating microRNAs are novel and minimal invasive markers for early detection of HCV based hepatocellular carcinoma. In this review, the current progress on the potential role of miRNA as biomarkers for detection of HCC and therapeutic targets are summarized. We concluded that the expression of microRNAis upregulated in the patients of hepatocellular carcinoma when compared with the healthy ones. In-depth studies of miRNA in patients of HCC as genetic biomarkers will improve the diagnosis. It will also improve the prognosis of early stage HCC patients. This will also help in identifying a suitable and effective therapeutic targets so as to reduce the chances of failure of chemotherapy.
Copyright (c) Iqra Khalid, Azra Quraishi, Freeha Fiaz
Iqra Khalid, Azra Quraishi, Freeha Fiaz. (2021) Validation of mRNAs in Early Diagnosis and Treatment of Hepatocellular Carcinoma, BioScientific Review, Volume 3, Issue 3.
-
Views
1015 -
Downloads
83
Article Details
Journal
Volume
Issue
Type
Language
Received At
Accepted At
